drug protocol number

CLEE011E2301

drug sponsor

Novartis

drug study

LEE011 (Ribociclib)

drug trial site

King Khalid University Hospital (Riyadh)_ King Faisal Specialist Hospital and Research Center (Riyadh)

drug status

Ongoing

drug phase